Found: 38
Select item for more details and to access through your institution.
Effect of Saccharomyces boulardii on Liver Diseases: A Systematic Review.
- Published in:
- Microorganisms, 2024, v. 12, n. 8, p. 1678, doi. 10.3390/microorganisms12081678
- By:
- Publication type:
- Article
Metabolic activity of intestinal microflora in patients with bronchial asthma.
- Published in:
- Clinics & Practice, 2019, v. 9, n. 1, p. 18, doi. 10.4081/cp.2019.1126
- By:
- Publication type:
- Article
Food Intolerance: The Role of Histamine.
- Published in:
- Nutrients, 2021, v. 13, n. 9, p. 3207, doi. 10.3390/nu13093207
- By:
- Publication type:
- Article
Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Role of Bile Acids in the Human Body and in the Development of Diseases.
- Published in:
- Molecules, 2022, v. 27, n. 11, p. 3401, doi. 10.3390/molecules27113401
- By:
- Publication type:
- Article
A Recent Ten-Year Perspective: Bile Acid Metabolism and Signaling.
- Published in:
- Molecules, 2022, v. 27, n. 6, p. 1983, doi. 10.3390/molecules27061983
- By:
- Publication type:
- Article
The Concept of Folic Acid in Health and Disease.
- Published in:
- Molecules, 2021, v. 26, n. 12, p. 3731, doi. 10.3390/molecules26123731
- By:
- Publication type:
- Article
Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0263880
- By:
- Publication type:
- Article
Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 1988, doi. 10.3390/ijms25041988
- By:
- Publication type:
- Article
Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 22, p. 16502, doi. 10.3390/ijms242216502
- By:
- Publication type:
- Article
Safety and Effectiveness of Essential Phospholipids Paste in Patients with Non-alcoholic Fatty Liver Disease or Viral Hepatitis.
- Published in:
- Turkish Journal of Gastroenterology, 2021, v. 32, n. 9, p. 750, doi. 10.5152/tjg.2021.20294
- By:
- Publication type:
- Article
Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?
- Published in:
- Turkish Journal of Gastroenterology, 2019, v. 30, n. 11, p. 964, doi. 10.5152/tjg.2019.18551
- By:
- Publication type:
- Article
A clinical variant of Coronavirus disease 2019 with diarrhea as the initial symptom compared with other variants.
- Published in:
- Minerva Gastroenterology, 2022, v. 68, n. 4, p. 487, doi. 10.23736/S2724-5985.21.02827-0
- By:
- Publication type:
- Article
Prevalence of Clostridium Difficile-Associated Diarrhoea in Hospitalised Patients (Results of a Russian Prospective Multicentre Study).
- Published in:
- Infectious Diseases & Therapy, 2018, v. 7, n. 4, p. 523, doi. 10.1007/s40121-018-0209-y
- By:
- Publication type:
- Article
Fatty Liver and Systemic Atherosclerosis in a Young, Lean Patient: Rule Out Lysosomal Acid Lipase Deficiency.
- Published in:
- Case Reports in Gastroenterology, 2019, v. 13, n. 3, p. 498, doi. 10.1159/000504646
- By:
- Publication type:
- Article
Gut Microbiota and Biomarkers of Intestinal Barrier Damage in Cirrhosis.
- Published in:
- Microorganisms, 2024, v. 12, n. 3, p. 463, doi. 10.3390/microorganisms12030463
- By:
- Publication type:
- Article
Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis.
- Published in:
- Microorganisms, 2023, v. 11, n. 9, p. 2202, doi. 10.3390/microorganisms11092202
- By:
- Publication type:
- Article
Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis.
- Published in:
- Microorganisms, 2023, v. 11, n. 4, p. 1017, doi. 10.3390/microorganisms11041017
- By:
- Publication type:
- Article
Clinical validation of the "7 × 7" questionnaire for patients with functional gastrointestinal disorders.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 6, p. 1042, doi. 10.1111/jgh.14546
- By:
- Publication type:
- Article
Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies.
- Published in:
- Drugs - Real World Outcomes, 2021, v. 8, n. 3, p. 369, doi. 10.1007/s40801-021-00250-x
- By:
- Publication type:
- Article
Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 12, p. 1956, doi. 10.1111/jgh.13407
- By:
- Publication type:
- Article
NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis.
- Published in:
- Gastroenterology & Hepatology from Bed to Bench, 2018, v. 11, n. 4, p. 325
- By:
- Publication type:
- Article
Gut Microbiota and Cytokine Profile in Cirrhosis.
- Published in:
- Journal of Clinical & Translational Hepatology, 2024, v. 12, n. 8, p. 689, doi. 10.14218/JCTH.2024.00090
- By:
- Publication type:
- Article
A Metabolic Activity Recovery of the Intestinal Microbiota in the Patients with Bronchial Asthma.
- Published in:
- Pulmonary Medicine, 2022, p. 1, doi. 10.1155/2022/9902438
- By:
- Publication type:
- Article
Dose–Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type I in Released-Active Form in the Light–Dark Test in Mice.
- Published in:
- Dose-Response, 2018, v. 16, n. 2, p. 1, doi. 10.1177/1559325818779752
- By:
- Publication type:
- Article
Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 3, p. 919, doi. 10.3390/jcm13030919
- By:
- Publication type:
- Article
Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 18, p. 6064, doi. 10.3390/jcm12186064
- By:
- Publication type:
- Article
Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis.
- Published in:
- Metabolites (2218-1989), 2023, v. 13, n. 7, p. 859, doi. 10.3390/metabo13070859
- By:
- Publication type:
- Article
Intestinal microbiota in the pathogenesis of chronic heart failure.
- Published in:
- Italian Journal of Medicine, 2020, v. 14, n. 1, p. 1, doi. 10.4081/itjm.2020.1185
- By:
- Publication type:
- Article
A correction of a gut microflora composition for the allergic bronchial asthma complex therapy.
- Published in:
- Italian Journal of Medicine, 2018, v. 12, n. 4, p. 260, doi. 10.4081/itjm.2018.1040
- By:
- Publication type:
- Article
Application of probiotics for acute respiratory tract infections.
- Published in:
- Italian Journal of Medicine, 2018, v. 12, n. 1, p. 32, doi. 10.4081/itjm.2018.931
- By:
- Publication type:
- Article
Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial
- Published in:
- Probiotics & Antimicrobial Proteins, 2023, v. 15, n. 3, p. 460, doi. 10.1007/s12602-021-09858-5
- By:
- Publication type:
- Article
The Evolution of Human Probiotics: Challenges and Prospects.
- Published in:
- Probiotics & Antimicrobial Proteins, 2020, v. 12, n. 4, p. 1291, doi. 10.1007/s12602-019-09628-4
- By:
- Publication type:
- Article
Intestinal Barrier and Gut Microbiota in Patients with Overlapping Irritable Bowel Syndrome and Functional Dyspepsia.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 11, p. 4166, doi. 10.1007/s10620-023-08117-7
- By:
- Publication type:
- Article
Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study.
- Published in:
- BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02690-x
- By:
- Publication type:
- Article
Pharmacokinetics and safety of fidaxomicin in patients with inflammatory bowel disease and Clostridium difficile infection: an open-label Phase IIIb/IV study (PROFILE).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Low Short-Chain-Fatty-Acid-Producing Activity of the Gut Microbiota Is Associated with Hypercholesterolemia and Liver Fibrosis in Patients with Metabolic-Associated (Non-Alcoholic) Fatty Liver Disease.
- Published in:
- Gastrointestinal Disorders, 2023, v. 5, n. 4, p. 464, doi. 10.3390/gidisord5040038
- By:
- Publication type:
- Article
Structure and Metabolic Activity of the Gut Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Combined with Functional Dyspepsia.
- Published in:
- Gastrointestinal Disorders, 2023, v. 5, n. 3, p. 296, doi. 10.3390/gidisord5030024
- By:
- Publication type:
- Article